Several c-Myc targets modulated by PEP/Ca2+ (i.e., Glut1, LDH-A) are associated with clinical colorectal cancer progression [35] and are also induced by K-Ras, commonly mutated in these cancers. The gene discussed is KRAS; the disease is colorectal cancer.